Korean

Notice

Notice

HOME > Notice

No.	Title	Write	Date
17	[IP Achievement] European Patent (EP) Grant for Neurodegenerative Disease Treatment Technology Derived from Daphne genkwa	엠테라파마	2026-04-02
16	[R&D Achievement] Identification of New Proteasome API (Active Pharmaceutical Ingredient) in MT101 via AI Platform	엠테라파마	2026-04-02
15	[Press Release] NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01	엠테라파마	2024-07-31
14	[Notice] MTHERA enters into MOU with Yuhan (April 2024)	엠테라파마	2024-07-31
13	[R&D] MT102: Selected for Scale-up TIPS, Korean Government R&D Funding Program	엠테라파마	2024-07-31
12	[Download] MT104: Selected as "20 excellent performance in agricultural R&D focused area of 2023"	엠테라파마	2024-07-31
11	[Press Release] MOU with GANGNEUNG-SI and Korea Ministry of Land, Infrastructure and Transport (Oct. 2023)	엠테라파마	2024-07-31
10	[Award] 2023 Hi Scale-up Demoday: Grand Prize (Oct. 2023)	엠테라파마	2024-07-31
9	[Press Release] MTHERA, P2a Clinical Study IND Approval of MT101 for Parkinson's Disease New Drug (August, 2023)	엠테라파마	2024-07-31
8	[News] NeuroBo Pharmaceuticals Enters Into Term Sheet With MThera Pharma to Out-license NB-01	엠테라파마	2023-08-03

12